QQ客服 官方微博 反馈留言

浏览/检索结果: 共6条，第1-6条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Attitude stabilization control method for quadrotor UAV based on ADRC 会议论文 International Conference on Communications, Signal Processing, and Systems, CSPS 2018, Dalian, China, 2018-07-14 作者:  Yang, Sen;  Xi, Leiping;  Gong, Guanghong;  Dong, Hairui 收藏  |  浏览/下载：22/0  |  提交时间：2019/12/30 Advantages with prophylactic PEG-rhG-CSF versus rhG-CSF in breast cancer patients receiving multiple cycles of myelosuppressive chemotherapy: an open-label, randomized, multicenter phase III study 期刊论文 BREAST CANCER RESEARCH AND TREATMENT, 2018, 卷号: 168, 期号: 2 作者:  Xie, Jie;  Cao, Jun;  Wang, Jing-fen;  Zhang, Bai-hong;  Zeng, Xiao-hua 收藏  |  浏览/下载：29/0  |  提交时间：2019/12/04 Breast cancer  Multicenter study  PEG-rhG-CSF  Neutropenia   Advantages with prophylactic PEG-rhG-CSF versus rhG-CSF in breast cancer patients receiving multiple cycles of myelosuppressive chemotherapy: an open-label, randomized, multicenter phase III study 期刊论文 BREAST CANCER RESEARCH AND TREATMENT, 2018, 卷号: 168, 期号: 2 作者:  Xie, Jie;  Cao, Jun;  Wang, Jing-fen;  Zhang, Bai-hong;  Zeng, Xiao-hua 收藏  |  浏览/下载：55/0  |  提交时间：2019/12/05 Breast cancer  Multicenter study  PEG-rhG-CSF  Neutropenia   Advantages with prophylactic PEG-rhG-CSF versus rhG-CSF in breast cancer patients receiving multiple cycles of myelosuppressive chemotherapy: an open-label, randomized, multicenter phase III study 期刊论文 Breast Cancer Research and Treatment, 2018, 卷号: 168, 期号: 2, 页码: 389-399 作者:  Xie, Jie;  Cao, Jun;  Wang, Jing-fen;  Zhang, Bai-hong;  Zeng, Xiao-hua 收藏  |  浏览/下载：13/0  |  提交时间：2019/12/27 Breast cancer  Multicenter study  Neutropenia  PEG-rhG-CSF   Phase II study of pseudomonas aeruginosa-mannose-sensitive hemagglutinin in combination with capecitabine for HER2-negative metastatic breast cancer pretreated with anthracycline and taxane 会议论文 作者:  Lv, Fangfang;  Cao, Jun;  Liu, Zhebin;  Wang, Zhong Hua;  Zhang, Jian 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/19 Randomized phase II trial comparing docetaxel with or without low-dose metronomic oral cyclophosphamide in first-line treatment of non-triple-negative advanced breast cancer 会议论文 作者:  Wang, Leiping;  Zhang, Jian;  Wang, Zhong Hua;  Wang, Biyun;  Cao, Jun 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/19